BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 12, 2002
View Archived Issues
Serono Enlists Marketing Muscle' Of Pfizer In $200M Rebif Alliance
Serono SA is teaming up with Pfizer Inc. to co-promote the multiple sclerosis drug Rebif in the United States, which will position Rebif directly against Biogen Inc.'s powerhouse drug Avonex. (BioWorld Today)
Read More
MedImmune Working Feverishly' On Resolving FluMist Concerns
Read More
Human Equivalent Of Nematode Dog-1 Implicates Mutated Protein In BRCA1 Breast Cancer Tumors
Read More
BioCryst Trims Staff, Changes Focus To Earlier-Stage Programs
Read More
Other News To Note
Read More
Bioethics Council Votes 10-7 For Therapeutic Cloning Moratorium
Read More
Appointments And Advancements
Read More